MOONLAKE IMMUNOTHERAPEUTICS Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MOONLAKE IMMUNOTHERAPEUTICS share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 27.15K shares, a 56.12% increase year-over-year.
- MOONLAKE IMMUNOTHERAPEUTICS share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-06-30 was 93.35K shares.
- MOONLAKE IMMUNOTHERAPEUTICS share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-03-31 was 93.35K shares.
- MOONLAKE IMMUNOTHERAPEUTICS share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-09-30 was 17.39K shares.
- MOONLAKE IMMUNOTHERAPEUTICS share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 48.80K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-09-30 | 27.15K shares 10-Q · filed 2025-11-05 | |
| 2025-06-30 | 93.35K shares 10-Q · filed 2025-11-05 | |
| 2025-03-31 | 93.35K shares 10-Q · filed 2025-08-05 | |
| 2024-12-31 | 48.80K shares 10-K · filed 2025-02-26 | |
| 2024-09-30 | 17.39K shares 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |